Skip to main content
Fig.Ā 2 | Diabetology & Metabolic Syndrome

Fig.Ā 2

From: Insulin resistance exhibits varied metabolic abnormalities in nonalcoholic fatty liver disease, chronic hepatitis B and the combination of the two: a cross-sectional study

Fig.Ā 2

Adjusted odds ratios (ORs) and 95% confidence intervals (CIs), and their trends of varieties of metabolic disorder diseases for quartiles of HOMA-IR. First quartile of HOMA-IR (Q1) in all subjects was set as reference. a Hypertension was defined as systolic blood pressure (SBP)ā€‰ā‰„ā€‰140Ā mmHg or diastolic blood pressure (DBP)ā€‰ā‰„ā€‰90Ā mmHg. b Hypertriglyceridemia was defined as a TG levelā€‰>ā€‰1.7Ā mmol/L. c High LDL-C level was defined as an LDL-C levelā€‰>ā€‰3.4Ā mmol/L. d Hyperuricemia was defined as males and females at >ā€‰420 and 360Ā Āµmol/L, respectively. e Metabolic symptom was diagnosis as meeting at least three of the following criteria: (1) Waistlineā€‰>ā€‰90Ā cm (male) and >ā€‰80Ā cm (female) and/or body mass index (BMI)ā€‰ā‰„ā€‰25Ā kg/m2; (2) elevated BPs (systolic blood pressure (SBP)ā€‰>ā€‰125Ā mmHg and/or diastolic blood pressure (DBP)ā€‰>ā€‰70Ā mmHg); (3) low HDL-C level; (4) fasting serum triglycerideā€‰ā‰„ā€‰1.7Ā mmol/L; (5) fasting plasma glucoseā€‰ā‰„ā€‰5.6Ā mmol/L. f ALT elevation was defined as ALTā€‰>ā€‰40Ā U/L

Back to article page